Volume 9, Issue 1, Pages (January 2012)

Slides:



Advertisements
Similar presentations
Risk of Life-Threatening Cardiac Events in Patients with Genotype-Confirmed Long-QT Syndrome and a Normal-Range QTc Ilan Goldenberg, MD,* Samuel Horr,
Advertisements

Benefit of magnetic resonance–conditional cardiac resynchronization therapy defibrillator: A case of cardiac sarcoidosis–involved cervical extradural lesion.
Carnitine deficiency induces a short QT syndrome Julien Roussel, PhD, François Labarthe, MD, PhD, Jerome Thireau, PhD, Fabio Ferro, PhD, Charlotte Farah,
Comparison of Low Versus High (>40 mm Hg) Pulse Pressure to Predict the Benefit of Cardiac Resynchronization Therapy for Heart Failure (from the Multicenter.
Volume 12, Issue 7, Pages (July 2015)
To the Editor— Amiloride concentrations in clinical practice
Volume 5, Issue 8, Pages (August 2008)
American Heart Journal
Volume 8, Issue 3, Pages (March 2011)
Risk of Recurrent Cardiac Events After Onset of Menopause in Women With Congenital Long-QT Syndrome Types 1 and 2Clinical Perspective by Jonathan Buber,
Volume 6, Issue 7, Pages (July 2009)
Cardiac ion channels in health and disease
Volume 11, Issue 1, Pages (January 2014)
Volume 15, Issue 1, Pages (January 2018)
One tachycardia with two entrainment responses: What is the mechanism?
Volume 13, Issue 11, Pages (November 2016)
Erratum Heart Rhythm Volume 8, Issue 4, (April 2011)
Volume 5, Issue 4, Pages (April 2008)
Sudden Cardiac Death, Mitral Valve Prolapse, and Long QT Syndrome
Volume 11, Issue 1, Pages (January 2014)
Volume 8, Issue 8, Pages (August 2011)
Alexander M. Walker, MD, DrPH, Dimitri Bennett, MD, MPH  Heart Rhythm 
Volume 5, Issue 6, Pages (June 2008)
Volume 13, Issue 8, Pages (August 2016)
Alexander M. Walker, MD, DrPH, Dimitri Bennett, MD, MPH  Heart Rhythm 
Arrhythmogenicity of weight-loss supplements marketed on the Internet
Volume 13, Issue 1, Pages (January 2016)
Volume 13, Issue 1, Pages (January 2016)
Volume 9, Issue 4, Pages (April 2012)
Volume 8, Issue 11, Pages (November 2011)
Volume 11, Issue 1, Pages (January 2014)
Volume 9, Issue 1, Pages (January 2012)
Volume 11, Issue 1, Pages (January 2014)
Volume 7, Issue 1, Pages (January 2010)
Volume 11, Issue 1, Pages (January 2014)
Volume 15, Issue 9, Pages (September 2018)
Volume 6, Issue 6, Pages (June 2009)
Volume 13, Issue 1, Pages (January 2016)
Volume 11, Issue 2, Pages (February 2014)
Volume 13, Issue 1, Pages (January 2016)
Volume 9, Issue 1, Pages (January 2012)
Volume 11, Issue 2, Pages (February 2014)
Volume 8, Issue 2, Pages (February 2011)
Volume 5, Issue 8, Pages (August 2008)
Ethnic and racial disparities in cardiac resynchronization therapy
Genotype-phenotype-guided medical and surgical intervention in long QT syndrome  Robyn J. Hylind, MS, CGC, Virginie Beausejour Ladouceur, MD, Francis Fynn-Thompson,
Volume 7, Issue 11, (November 2010)
Volume 16, Issue 1, Pages e3-e16 (January 2019)
Volume 9, Issue 1, Pages (January 2012)
Volume 14, Issue 12, Pages (December 2017)
Volume 16, Issue 1, Pages 3-9 (January 2019)
Volume 9, Issue 8, Pages S14-S17 (August 2012)
Michael R. Gold, MD, PhD, FHRS  Heart Rhythm 
Volume 15, Issue 1, Pages (January 2018)
Volume 13, Issue 1, (January 2016)
An inferior myocardial infarction with conduction abnormalities
Simrit K. Warring, MS, Heather N. Anderson, MD, J
Volume 7, Issue 11, Pages (November 2010)
Intangible benefits of volunteering with the Heart Rhythm Society
Volume 10, Issue 4, Pages (April 2013)
Volume 6, Issue 3, Pages (March 2009)
HRS collaborates with leading medical societies to launch a voluntary laboratory accreditation program and drive quality improvement  John D. Day, MD,
Volume 8, Issue 3, Pages (March 2011)
Volume 6, Issue 2, Pages (February 2009)
Polygenic case of long QT syndrome confirmed through functional characterization informs the interpretation of genetic screening results  Malcolm Hoshi,
Use of topical lidocaine in eliminating mechanically stimulated ventricular fibrillation in a patient with short QT syndrome  Maria J. Farag, BS, Joseph.
Volume 14, Issue 1, (January 2017)
Left cardiac sympathetic denervation for recurrent ventricular tachyarrhythmias in children with congenital heart disease  Erica D. Bonura, MD, Christopher.
2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy  Jeffrey A. Towbin, MS, MD, William.
Volume 16, Issue 6, Pages (June 2019)
Presentation transcript:

Volume 9, Issue 1, Pages 49-56 (January 2012) Trigger-specific ion-channel mechanisms, risk factors, and response to therapy in type 1 long QT syndrome  Ilan Goldenberg, MD, Princy Thottathil, MD, Coeli M. Lopes, PhD, Arthur J. Moss, MD, Scott McNitt, MS, Jin O-Uchi, MD, PhD, Jennifer L. Robinson, MS, Wojciech Zareba, MD, PhD, Michael J. Ackerman, MD, Elizabeth S. Kaufman, MD, Jeffrey A. Towbin, MD, Michael Vincent, MD, Alon Barsheshet, MD  Heart Rhythm  Volume 9, Issue 1, Pages 49-56 (January 2012) DOI: 10.1016/j.hrthm.2011.08.020 Copyright © 2012 Heart Rhythm Society Terms and Conditions

Figure 1 Gender and trigger-specific risk for cardiac events in LQT1. Kaplan–Meier cumulative probability of (A) exercise-triggered events, (B) arousal-triggered events, and (C) sleep/rest-triggered events by gender. LQT1 = long-QT syndrome type 1. Heart Rhythm 2012 9, 49-56DOI: (10.1016/j.hrthm.2011.08.020) Copyright © 2012 Heart Rhythm Society Terms and Conditions

Figure 2 Mutation location and trigger-specific risk for cardiac events in LQT1. Kaplan–Meier cumulative probability of (A) exercise-triggered events, (B) arousal-triggered events, and (C) sleep/rest-triggered events by mutation location and type. C/N = C/N terminus; C-loops = cytoplasmic loops; LQT1 = long-QT syndrome type 1. Heart Rhythm 2012 9, 49-56DOI: (10.1016/j.hrthm.2011.08.020) Copyright © 2012 Heart Rhythm Society Terms and Conditions

Figure 3 Cumulative probability of trigger-specific first and recurrent cardiac events in LQT1. Kaplan–Meier cumulative probabilities of first and recurrent cardiac events of the same type: exercise-triggered events (A), arousal-triggered events (B), and sleep/rest-triggered events (C). For the assessment of the rate of recurrent events, follow-up is restarted at the time for the first event. LQT1 = long-QT syndrome type 1. Heart Rhythm 2012 9, 49-56DOI: (10.1016/j.hrthm.2011.08.020) Copyright © 2012 Heart Rhythm Society Terms and Conditions